WO2003104410A3 - Enzymes - Google Patents

Enzymes Download PDF

Info

Publication number
WO2003104410A3
WO2003104410A3 PCT/US2003/017907 US0317907W WO03104410A3 WO 2003104410 A3 WO2003104410 A3 WO 2003104410A3 US 0317907 W US0317907 W US 0317907W WO 03104410 A3 WO03104410 A3 WO 03104410A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzymes
relate
enzm
polynucleotides
agonists
Prior art date
Application number
PCT/US2003/017907
Other languages
French (fr)
Other versions
WO2003104410A2 (en
Inventor
Soo Y Lee
Amy E Kable
Narinder K Chawla
Patricia M Mason
April J A Hafalia
Joseph P Marquis
Thomas W Richardson
Vicki S Elliott
Shanya D Becha
Sean A Bulloch
Phillip R Hawkins
Pei Jin
Kimberly J Gietzen
Amy D Wilson
Hsin-Ru Chang
Reena Khare
Anita Swarnakar
Uyen K Tran
Brooke M Emerling
Original Assignee
Incyte Corp
Soo Y Lee
Amy E Kable
Narinder K Chawla
Patricia M Mason
April J A Hafalia
Joseph P Marquis
Thomas W Richardson
Vicki S Elliott
Shanya D Becha
Sean A Bulloch
Phillip R Hawkins
Pei Jin
Kimberly J Gietzen
Amy D Wilson
Hsin-Ru Chang
Reena Khare
Anita Swarnakar
Uyen K Tran
Brooke M Emerling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US38711902P priority Critical
Priority to US60/387,119 priority
Priority to US39066202P priority
Priority to US60/390,662 priority
Application filed by Incyte Corp, Soo Y Lee, Amy E Kable, Narinder K Chawla, Patricia M Mason, April J A Hafalia, Joseph P Marquis, Thomas W Richardson, Vicki S Elliott, Shanya D Becha, Sean A Bulloch, Phillip R Hawkins, Pei Jin, Kimberly J Gietzen, Amy D Wilson, Hsin-Ru Chang, Reena Khare, Anita Swarnakar, Uyen K Tran, Brooke M Emerling filed Critical Incyte Corp
Publication of WO2003104410A2 publication Critical patent/WO2003104410A2/en
Publication of WO2003104410A3 publication Critical patent/WO2003104410A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity

Abstract

Several embodiments of the invention relate to human enzymes (ENZM) and polynucleotides which identify and encode these enzymes. Certain embodiments of the invention also relate to expression vectors, host cells, antibodies, agonists and antagonists. Other embodiments relate to methods of diagnosing, treating or preventing disorders associated with the aberrant expression of these enzymes.
PCT/US2003/017907 2002-06-07 2003-06-05 Enzymes WO2003104410A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US38711902P true 2002-06-07 2002-06-07
US60/387,119 2002-06-07
US39066202P true 2002-06-21 2002-06-21
US60/390,662 2002-06-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003238930A AU2003238930A1 (en) 2002-06-07 2003-06-05 Enzymes

Publications (2)

Publication Number Publication Date
WO2003104410A2 WO2003104410A2 (en) 2003-12-18
WO2003104410A3 true WO2003104410A3 (en) 2004-11-11

Family

ID=29739930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/017907 WO2003104410A2 (en) 2002-06-07 2003-06-05 Enzymes

Country Status (2)

Country Link
AU (1) AU2003238930A1 (en)
WO (1) WO2003104410A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20040121335A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
WO2004060278A2 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
WO2005117270A2 (en) 2004-05-24 2005-12-08 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
WO2007014045A2 (en) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CA2663029C (en) 2006-09-14 2016-07-19 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8534447B2 (en) 2008-09-16 2013-09-17 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
WO2010093943A1 (en) 2009-02-12 2010-08-19 Ibis Biosciences, Inc. Ionization probe assemblies
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc Systems for bioagent identification
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
ES2628739T3 (en) 2009-10-15 2017-08-03 Ibis Biosciences, Inc. Multiple displacement amplification

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061471A2 (en) * 1998-05-29 1999-12-02 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 15 September 2000 (2000-09-15), STRAUSBERG R.: "National Institutes of Health, Mammalian Gene Collection (MGC) http://www.ncbi.nlm.nih.gov/MGC/", XP002981020, Database accession no. BE747946 *
DATABASE GENBANK [online] 5 April 2001 (2001-04-05), RUBEN S.M. ET AL: "Nucleic acids encoding 4277 human colon cancer-associated polypeptides, useful for preventing, diagnosing and/or treating colorectal cancers.", XP002981021, Database accession no. AAH34645 *

Also Published As

Publication number Publication date
AU2003238930A1 (en) 2003-12-22
WO2003104410A2 (en) 2003-12-18
AU2003238930A8 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
AT355293T (en) Substituted 7-aza- (2.2.1) bicycloheptanes for the treatment of diseases
BR0307788A (en) reduction method and treatment of uv-b-induced immunosuppression
BR0015962A (en) Compounds having multiple bonds that are adrenergic (beta) 2 agonists useful in the treatment and prevention of respiratory diseases
EA200100822A1 (en) Baff, related to it blocking agents and their application in stimulation and inhibition of b-cells and immunoglobulins in immune reactions
EA200301232A1 (en) New aryl sulphonamide connections and their application for treatment of obesity, type ii diabetes and central nervous disorders
BRPI0405450A (en) Coating Agent
EA200401551A1 (en) Obtaining sulphinylacetamide
BRPI0413495A (en) prion-specific peptide reagents and their uses
EA200400586A1 (en) Substituted thyocetamides
EA200901313A1 (en) Bluton tyrosinkinase inhibitors
BRPI0413018A (en) compound, and method for treating or preventing autoimmune diseases and / or one or more symptoms associated with them
EA200400312A1 (en) ANTAGONISTIC ANTIBODIES AGAINST HTNFSF13b MAN
WO2003057838A3 (en) Antibodies against the muc18 antigen
BG105886A (en) CRYSTAL STRUCTURE OF cPLA 2 AND METHODS OF IDENTIFYING ITS AGONISTS AND ANTAGONISTS
IT1394617B1 (en) Integrated Methods for determining the corrosivity ', aging, of the fingerprint, as well as the diagnosis, decontamination, the depolarization and detoxification of oils
WO2004044168A8 (en) Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
EA200700702A1 (en) Loksapina analogues and methods of their application
MXPA05001694A (en) Bmp-2 estrogen responsive element and methods of using the same.
AT323680T (en) 7-arylsulphonamide-2,3,4,5-tetrahydro-1h-benzodaazepine with 5-ht6 receptor affinity for the treatment of central nervous diseases
BR0114903A (en) 7-azaindoles, their application as phosphodiesterase 4 inhibitors and processes for their preparation
BR9912406A (en) Substituted anilide compounds and methods
BR0108866A (en) Il-8 Receptor Antagonists
BRPI0414215A (en) thienopyrazoles
EA200401198A1 (en) ANTIBODIES AGAINST αvβ6
BRPI0414598A (en) replaced indoles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP